It took a pair of intrepid homeowners to see beyond the insults of the centuries and bring back the house’s soul …read more
From:: DIY this old house

Foreclosures | Mortgages | Financing
It took a pair of intrepid homeowners to see beyond the insults of the centuries and bring back the house’s soul …read more
From:: DIY this old house
This Old House landscape contractor Roger Cook helps a homeowner repair a cracked stone walkway …read more
From:: DIY this old house
Affymetrix Inc. shares jumped 50% after Thermo Fisher Scientific Inc. said late Friday it agreed to acquire the biological test company for $14 a share cash, or $1.3 billion. Shares of Affymetrix, which had been halted at $9.21 prior to the announcement, surged 50% to $13.80 after hours. Board members from both companies have approved the transaction, according to Thermo Fisher and Affymetrix. Subject to approval from Affymetrix shareholders, Thermo Fisher expects the deal to close at the end of the second quarter.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
The J. Ronald Terwilliger Foundation for Housing America’s Families announced recently that Doug Bibby, the president of the National Multifamily Housing Council, joined the foundation’s advisory board. …read more
From:: Real Estate Wire
Thermo Fisher Scientific Inc. said late Friday it agreed to acquire biological test company Affymetrix Inc. for $14 a share cash, or $1.3 billion. Shares of Affymetrix had been halted at $9.21 prior to the announcement and are expected to resume trading at 6:15 p.m. Eastern. Board members from both companies have approved the transaction, according to Thermo Fisher and Affymetrix. Subject to approval from Affymetrix shareholders, Thermo Fisher expects the deal to close at the end of the second quarter.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Charter Communications Inc. said Friday that it has received the go-ahead for its merger with Time Warner Cable Inc. in the state of New York. As a condition for the approval, Charter is obligated to provide a minimum speed of 60 megabits per second and offer a speed of 300 mbps throughout the state. The company will also expand its network to provide services in unserved areas.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
November was a sluggish month for consumer credit, moving at the second-slowest pace of the year. Compared to usual, an article in The Wall Street Journal explained that Friday’s report showed slower growth in federal student loan. …read more
From:: Real Estate Wire
Humana Inc. said Friday it expects a net decline in its individual medical health plans of 200,000 to 300,000 members. That takes into account plans that comply with the Affordable Care Act on and off health exchanges and plans that don’t, the insurer said in a filing. The company expects to gain 100,000 to 120,000 members for its individual Medicare Advantage plans for the year, but a decline in Medicare Advantage group membership of 120,000 to 125,000 members due to a previously disclosed loss of a large account. The company reiterated fiscal 2015 adjusted earnings of $7.75 a share. Shares of Humana rose 0.5% in late trading Friday after ending the regular session down 1.3%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
HCA Holding Inc. shares rose in the extended session Friday after the hospital operator said it expected to exceed its adjusted earnings outlook for the year. HCA shares advanced 2.7% to $66. The company said it expects adjusted earnings before interest, taxes, depreciation and amortization of about $7.9 billion for 2015. Previously, HCA had forecast $7.8 billion. Analysts surveyed by FactSet had estimated adjusted EBITDA of $7.76 billion.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Biotech stocks were battered this week with the iShares Nasdaq Biotechnology ETF tumbling 1.8% on Friday for a weekly decline of 11%, its worst one-week performance since the end of September. Even with the Dow Jones Industrial Average and the S&P 500 both posting steep losses, biotech shares underperformed the broader market significantly. The sector, which had been one of the best performers during the bull market, has come under pressure after peaking in July, particularly after Hillary Clinton criticized drug companies on how they price specialty drugs.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News